Ivan Cheung is a seasoned executive in the pharmaceutical and healthcare services sectors, currently serving as CEO and Member of the Board of Directors at NextPoint Therapeutics, Inc. since January 2024 and as a Member of the Board of Directors at Lexicon Pharmaceuticals, Inc. since December 2024. Additionally, Ivan Cheung is a Senior Advisor at TPG as of September 2023. Previously, Ivan Cheung held various key roles at Eisai US and Eisai Co., Ltd., including U.S. CEO & Global President of the Neurology Business Group and Deputy President of Global Oncology and Neurology. With a foundation in corporate strategy and financial management from positions at Booz Allen Hamilton and various leadership roles at Eisai, Ivan Cheung brings extensive expertise backed by an MBA from Harvard University and a Bachelor's degree in Civil/Environmental Engineering and Economics from Duke University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices